A Pilot Safety Study of Vaccination With Autologous, Lethally Irradiated Colorectal Cancer Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Human Granulocyte-Macrophage Stimulating Factor

Trial Profile

A Pilot Safety Study of Vaccination With Autologous, Lethally Irradiated Colorectal Cancer Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Human Granulocyte-Macrophage Stimulating Factor

Suspended
Phase of Trial: Phase I

Latest Information Update: 21 Nov 2016

At a glance

  • Drugs Tumour cell vaccine-GVAX (Primary)
  • Indications Colorectal cancer; Liver metastases
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 17 Nov 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2018.
    • 17 Nov 2016 Planned End Date changed from 1 Jul 2025 to 1 Jul 2030.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top